A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS

Clicks: 345
ID: 274672
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #23 of 72 articles by views in Cell

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Vaccines are urgently needed to control the ongoing pandemic COVID-19 and previously emerging MERS/SARS caused by coronavirus (CoV) infections. The CoV spike receptor-binding domain (RBD) is an attractive vaccine target but is undermined by limited immunogenicity. We describe a dimeric form of MERS- …
Reference Key
l2020cella Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Dai L;Zheng T;Xu K;Han Y;Xu L;Huang E;An Y;Cheng Y;Li S;Liu M;Yang M;Li Y;Cheng H;Yuan Y;Zhang W;Ke C;Wong G;Qi J;Qin C;Yan J;Gao GF;;
Journal Cell
Year 2020
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.